These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 929508)

  • 1. Platelet factor 3: quantitation and characterization.
    Wu VY; McCoy LE
    Thromb Res; 1977 Nov; 11(5):581-93. PubMed ID: 929508
    [No Abstract]   [Full Text] [Related]  

  • 2. Isolation and physicochemical and immunologic characterization of human platelet factor 3.
    Sharma NC; Mohammad SF; Chuang HY; Mason RG
    Thromb Res; 1979; 16(5-6):673-87. PubMed ID: 118541
    [No Abstract]   [Full Text] [Related]  

  • 3. A standardized bioassay for platelet factor 3 released by kaolin.
    Pérez-Requejo JL
    Br J Haematol; 1976 May; 33(1):39-51. PubMed ID: 1268089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of human plasma lipoproteins on platelet aggregation and platelet factor 3 activity in vitro.
    Miller NE; Nordoy A
    Atherosclerosis; 1977 Oct; 28(2):181-6. PubMed ID: 199206
    [No Abstract]   [Full Text] [Related]  

  • 5. Determination of platelet factor 3 by thrombin generation using a micro-coagulation assay.
    Kirchhof B; Balleisen L
    Thromb Res; 1982 Aug; 27(3):303-10. PubMed ID: 6890246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. STUDIES ON PLATELET FACTOR-3 AVAILABILITY.
    SPAET TH; CINTRON J
    Br J Haematol; 1965 May; 11():269-75. PubMed ID: 14282064
    [No Abstract]   [Full Text] [Related]  

  • 7. Isolation and characterization of lipid-protein particles containing platelet factor 3 released from human platelets.
    Sandberg H; Andersson LO; Höglund S
    Biochem J; 1982 Apr; 203(1):303-11. PubMed ID: 7103943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. THE KAOLIN CLOTTING TIME OF PLATELET-RICH PLASMA: A TEST OF PLATELET FACTOR-3 AVAILABILITY.
    HARDISTY RM; HUTTON RA
    Br J Haematol; 1965 May; 11():258-68. PubMed ID: 14282063
    [No Abstract]   [Full Text] [Related]  

  • 9. Lack of platelet factor-3 activation after incubation of platelet-rich plasma with kaolin in the rat.
    Clerck FD; Goossens J; Beerens M
    Experientia; 1976 Dec; 32(12):1602-3. PubMed ID: 1021463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of phospholipase C on platelet factor 3 in human blood platelets.
    Otnaess AB; Prydz H
    Thromb Haemost; 1977 Feb; 37(1):29-35. PubMed ID: 576515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet factor 3 in membranes and granules of human platelets.
    Farská I; Pudlák P; Posedĕlová H
    Acta Univ Carol Med Monogr; 1972; 53():141-6. PubMed ID: 4670726
    [No Abstract]   [Full Text] [Related]  

  • 12. [Platelet factor 3].
    Isobe J
    Rinsho Byori; 1987 Jun; Spec No 71():183-91. PubMed ID: 3306039
    [No Abstract]   [Full Text] [Related]  

  • 13. The platelet membrane as a catalytic surface in thrombin generation: availability of platelet factor 1 and platelet factor 3.
    Bode AP; Dombrose FA; Lentz BR; Roberts HR
    Ann N Y Acad Sci; 1981; 370():348-58. PubMed ID: 6943964
    [No Abstract]   [Full Text] [Related]  

  • 14. Platelet factor 3 assay and the availability of platelet factor 3 in collagen or thrombin stimulated platelets.
    Brox JH; Osterud B
    Thromb Res; 1984 Mar; 33(5):555. PubMed ID: 6719401
    [No Abstract]   [Full Text] [Related]  

  • 15. [Phospholipids and platelet procoagulant activity in myeloproliferative syndromes].
    Martínez E; César J; Navarro JL; Mercado A; Pardo A; García Avello A; García Frade J
    Sangre (Barc); 1985; 30(1):22-7. PubMed ID: 4039850
    [No Abstract]   [Full Text] [Related]  

  • 16. [Platelet factor 3 (PF3) and primary hemostasis: ditazol test].
    Di Micco B; Boeri F; Pagliara E; Cinque MR; Messina MF; Marcacci M
    Pediatria (Napoli); 1979 Jun; 87(2):237-43. PubMed ID: 44904
    [No Abstract]   [Full Text] [Related]  

  • 17. Proceedings: Activation of endotoxin-induced intravascular coagulation in congenitally C6-deificient rabbits.
    Lohmann E; Müller-Berghaus G
    Thromb Diath Haemorrh; 1975 Nov; 34(2):603-4. PubMed ID: 1198528
    [No Abstract]   [Full Text] [Related]  

  • 18. Editorial: Platelet function tests and their interpretation.
    Weiss HJ
    J Lab Clin Med; 1976 Jun; 87(6):909-12. PubMed ID: 932522
    [No Abstract]   [Full Text] [Related]  

  • 19. The possible role of platelet coagulant activities in the pathogenesis of venous thrombosis.
    Walsh PN
    Thromb Diath Haemorrh; 1975 Jun; 33(3):435-43. PubMed ID: 1154305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Platelet factor 3 (P-F-3) in chronic renal failure. Effect of dialysis].
    Lasierra Cirujeda J; Sánchez Casajus A; Vilades Juan E
    Rev Clin Esp; 1980 Mar; 156(5):321-4. PubMed ID: 7384579
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.